EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Radiofrequency or cryoablation or medical therapy for paroxysmal atrial fibrillation: An indirect comparison of effectiveness

Roberto Brunoro iD, Lorenzo Di Spazio iD, Melania Rivano iD, Luca Cancanelli iD, Chiara Nunzia Fasano Celentano, Daniele Mengato iD, Andrea Messori iD

Journal of Arrhythmia · 2025-04 · 41 (2)

DOI: 10.1002/joa3.70054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Arrhythmia, 2025-04. Verfasst von Roberto Brunoro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy University of Milano Milan Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Paroxysmal atrial fibrillation (PAF) is commonly treated with pharmacological therapies, but these may be insufficient for symptom control. Radiofrequency and cryoballoon ablation have emerged as alternative strategies. This study aimed to compare the efficacy of cryoballoon ablation, radiofrequency ablation, and anti‐arrhythmic drugs as initial therapies for symptomatic PAF based on randomized trial data.

Methods

Data were extracted from randomized trials, and individual patient data were reconstructed from Kaplan–Meier curves using artificial intelligence techniques. Time‐to‐event analysis was performed to evaluate arrhythmia recurrence, with hazard ratios (HRs) as the primary measure of efficacy. A heterogeneity analysis was conducted to assess variability between studies.

Results

Five randomized trials were included in the analysis. Significant between‐trial heterogeneity was observed. Both cryoballoon ablation (HR 0.48; 95% CI: 0.36–0.63; p < .001) and radiofrequency ablation (HR 0.54; 95% CI: 0.37–0.80; p = .002) demonstrated superior efficacy compared to anti‐arrhythmic drug therapy in reducing arrhythmia recurrence.

Conclusions

Cryoballoon and radiofrequency ablation are more effective than anti‐arrhythmic drugs for initial therapy in symptomatic PAF. These findings support the use of ablation techniques as preferred interventions in this patient population.

Schlagwörter

Stichwörter der Autor:innen

cryoballoon ablationindirect comparisonparoxysmal atrial fibrillationradiofrequency ablation

Autor:innen und Institutionen

  • Department of Pharmacy University of Milano Milan Italy.
  • Hospital Pharmacy Department, Santa Chiara Trento Hospital Azienda Provinciale per i Servizi Sanitari (APSS) Trento Italy.
  • Hospital Pharmacy Department Azienda Ospedaliero Universitaria Cagliari Italy.
  • Hospital Pharmacy Department Azienda Ulss 2 Marca Trevigiana Treviso Italy.
  • Hospital Pharmacy Department Azienda Ulss 3 Serenissima Mirano Italy.
  • Hospital Pharmacy Department Azienda Ospedale-Università Padova Padua Italy.

ORCID-Profile: Roberto Brunoro, Lorenzo Di Spazio, Melania Rivano, Luca Cancanelli, Daniele Mengato, Andrea Messori

Zitieren

APA

Brunoro, R., Di Spazio, L., Rivano, M., Cancanelli, L., Celentano, C. N. F., Mengato, D., & Messori, A. (2025). Radiofrequency or cryoablation or medical therapy for paroxysmal atrial fibrillation: An indirect comparison of effectiveness. Journal of Arrhythmia, 41(2). https://doi.org/10.1002/joa3.70054

Vancouver

Brunoro R, Di Spazio L, Rivano M, Cancanelli L, Celentano CNF, Mengato D, et al. Radiofrequency or cryoablation or medical therapy for paroxysmal atrial fibrillation: An indirect comparison of effectiveness. Journal of Arrhythmia. 2025;41(2). doi:10.1002/joa3.70054

BibTeX
@article{Brunoro2025,
  author = {Brunoro, Roberto and Di Spazio, Lorenzo and Rivano, Melania and Cancanelli, Luca and Celentano, Chiara Nunzia Fasano and Mengato, Daniele and Messori, Andrea},
  title = {Radiofrequency or cryoablation or medical therapy for paroxysmal atrial fibrillation: An indirect comparison of effectiveness},
  journal = {Journal of Arrhythmia},
  year = {2025},
  volume = {41},
  number = {2},
  doi = {10.1002/joa3.70054}
}
Kostenlos starten →